TETRAPHASE PHARMACEUTICALS INC (TTPH) Covered Calls

TETRAPHASE PHARMACEUTICALS INC covered calls Tetraphase Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in creating antibiotics for serious and life-threatening multidrug-resistant infections. Its product candidate eravacycline is a fully synthetic tetracycline derivative.

You can sell covered calls on TETRAPHASE PHARMACEUTICALS INC to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TTPH (prices last updated Mon 1:45 PM ET):

TETRAPHASE PHARMACEUTICALS INC (TTPH) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.92 0.00 2.91 2.92 427K - 0.2B
Covered Calls For TETRAPHASE PHARMACEUTICALS INC (TTPH)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 2.5 0.55 2.37 5.5% 77.2%
Nov 16 2.5 0.65 2.27 10.1% 68.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Tetraphase Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops next-generation tetracycline antibiotics that address unmet needs such as the treatment of serious drug-resistant and gram-negative infections. The company's lead product candidate, eravacycline is a fully synthetic tetracycline derivative that is developed as a broad-spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multi-drug resistant infections, including multi-drug resistant Gram-negative infections. It has developed an emerging pipeline of potent novel antibiotics that provide a portfolio of intravenous and oral drug candidates with the potential to treat a wide range of infections, including broad-spectrum and selective-spectrum infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.